FDA Person
Office of Regulatory AffairsDaniel L. Zheng
View detailed information about Daniel L. Zheng, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of Regulatory Affairs. Took part in 25 inspections of 24 companies, 2023–2026.
Inspections (25)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 15, 2026 | Eisai, Inc. | Not classified | #1335274 | |
| June 10, 2026 | Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services | Not classified | Drug Quality Assurance | #1321518 |
| May 15, 2026 | Sciegen Pharmaceuticals Inc | Not classified | Drug Quality Assurance | #1317246 |
| April 9, 2026 | Lantheus Medical Imaging, Inc. | Not classified | Drug Quality Assurance | #1312058 |
| February 25, 2026 | SCIARRA AEROMED, INC | Not classified | #1305424 | |
| November 5, 2025 | Fresenius Kabi Compounding, LLC | Not classified | Drug Quality Assurance | #1290368 |
| September 11, 2025 | Tropichem Research Labs, LLC dba Vetio | Not classified | Monitoring of Marketed Animal Drugs, Feeds, and Devices | #1281570 |
| July 25, 2025 | Avista Pharma Solutions, Inc. | VAI | Drug Quality Assurance | #1278383 |
| May 29, 2025 | Reactimex S.A. de C.V. | Not classified | #1275318 | |
| May 23, 2025 | Symrise, S. de R.L de C.V. | Not classified | #1271374 | |
| May 16, 2025 | Cyan Labs S.A. de C.V. | VAI | Drug Quality Assurance | #1263659 |
| April 18, 2025 | Sun Pharmaceutical Industries, Inc. | VAI | Drug Quality Assurance | #1256351 |
| February 25, 2025 | Alnylam Pharmaceuticals Inc. | VAI | Drug Quality Assurance | #1262276 |
| January 17, 2025 | Rentschler Biopharma Inc. | Not classified | #1259307 | |
| November 7, 2024 | Milbar Laboratories, Inc. | VAI | Drug Quality Assurance | #1253807 |
| July 29, 2024 | Denison Pharmaceuticals, LLC | OAI | Drug Quality Assurance | #1240591 |
| May 17, 2024 | Novel Laboratories, Inc. d.b.a Lupin Somerset | VAI | Generic Drug Evaluation | #1235495 |
| March 22, 2024 | MSN Laboratories Private Limited, Unit-II | VAI | Drug Quality Assurance | #1236036 |
| March 15, 2024 | Kekule Pharma Limited | VAI | Drug Quality Assurance | #1232940 |
| February 15, 2024 | EyePoint Pharmaceuticals, Inc. | Not classified | Drug Quality Assurance | #1230113 |
Documents (37)
- 483 · South Berwick Pharmacy Seacoast Compounding, Inc. · September 30, 2022
- 483 · New England Life Care, Inc. dba Advanced Compounding Solutions · April 28, 2022
- EIR · Berkshire Sterile Manufacturing, LLC · October 15, 2021
- EIR · Rentschler Biopharma Inc. · January 17, 2025
- 483 · Kekule Pharma Limited · March 15, 2024
- 483 · Fresenius Kabi Compounding, LLC · November 5, 2025
- EIR · Genzyme Corporation · June 25, 2022
- 483 · Catalent Massachusetts, LLC · November 30, 2021
- EIR · Avista Pharma Solutions, Inc. · July 25, 2025
- 483 · Symrise, S. de R.L de C.V. · May 23, 2025
- 483 · Milbar Laboratories, Inc. · November 7, 2024
- 483 · Alnylam Pharmaceuticals Inc. · February 25, 2025
- 483 · The W.S. Badger Company, Inc. · June 1, 2023
- EIR · Catalent Massachusetts, LLC · November 30, 2021
- 483 · Tropichem Research Labs, LLC dba Vetio · September 11, 2025
- 483 · Cyan Labs S.A. de C.V. · May 16, 2025
- 483 · MSN Laboratories Private Limited, Unit-II · March 22, 2024
- 483 · Chartwell Pharmaceuticals Amityville, LLC · December 21, 2022
- 483 · EyePoint Pharmaceuticals, Inc. · February 15, 2024
- 483 · South Berwick Pharmacy Seacoast Compounding, Inc. · September 30, 2022
- 483 · Amneal Pharmaceuticals, LLC · February 10, 2022
- 483 · Denison Pharmaceuticals, LLC · July 29, 2024
- 483 · Lyne Laboratories, Inc. · October 21, 2022
- 483 · Genzyme Corporation · July 25, 2022
- 483 · Atlantic Management Resources Ltd. · August 10, 2022
- 483 · Rentschler Biopharma Inc. · January 17, 2025
- 483 · Hopkinton Drug, Inc. · November 2, 2020
- 483 · Avista Pharma Solutions, Inc. · July 25, 2025
- 483 · Pharmasol Corporation · June 14, 2021
- 483 · Lohxa, LLC · August 3, 2023
- 483 · Eugia US Manufacturing LLC · December 22, 2023
- 483 · Apothecus Pharmaceutical Corp. · October 6, 2023
- 483 · Denison Pharmaceuticals, LLC · February 9, 2023
- 483 · Berkshire Sterile Manufacturing, LLC · October 15, 2021
- 483 · Sun Pharmaceutical Industries, Inc. · April 18, 2025
- 483 · Lantheus Medical Imaging, Inc. · April 9, 2026
- 483 · SCIARRA AEROMED, INC · February 25, 2026
Frequently inspected with (10)
Lori M. Newman
Deputy Director
6 shared
Armen H. Youssoufian
3 shared
Ogechi C. Nna
3 shared
Sean R. Marcsisin
Senior Consumer Safety Officer - Pharmaceutical Quality
3 shared
Ifechimere I. Okafor
investigator
2 shared
Claude Noel Y. Zanetsie
1 shared
Divek R. Jumani
investigator
1 shared
Emmanuel T. Donyina
1 shared
James R. Birkenstamm
1 shared
Jonathan G. Matrisciano
Program Division Director/District Director
1 shared
Related Office
Person Information
Name
Daniel L. Zheng
Title
M.S., Consumer Safety Officer at FDA
Role
Regulatory Personnel
ID: 5e3d993f-654e-4d40-a2c8-69c5e396499f
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.